125 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
51 | 9508190 | Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study Group. | 1998 Mar | 1 |
52 | 9589033 | Biomodulation of Fluorouracil in colorectal cancer. | 1998 | 2 |
53 | 9619746 | 5-Fluorouracil plus interferon alpha-2a compared to 5-fluorouracil alone in the treatment of advanced colon carcinoma: a multicentric randomized study. | 1998 | 2 |
54 | 9726437 | Biomodulation with sequential intravenous IFN-alpha2b and 5-fluorouracil as second-line treatment in patients with advanced colorectal cancer. | 1998 Aug | 1 |
55 | 9839521 | Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05. | 1998 Dec 2 | 1 |
56 | 10388104 | Gene Regulation and Clinical Roles for Interferons in Neoplastic Diseases. | 1998 | 4 |
57 | 9020295 | Treatment of advanced pancreatic adenocarcinoma with 5-FU, leucovorin, interferon-alpha-2b, and cisplatin. | 1997 Feb | 4 |
58 | 9070485 | Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD). | 1997 Mar 15 | 6 |
59 | 9155534 | Biochemical mechanisms of interferon modulation of 5-fluorouracil activity in colon cancer cells. | 1997 Mar | 7 |
60 | 9815792 | A pilot study of gamma-1b-interferon in combination with fluorouracil, leucovorin, and alpha-2a-interferon. | 1997 Jul | 6 |
61 | 9815814 | Combination therapy with 5-fluorouracil and IFN-alpha2a induces a nonrandom increase in DNA fragments of less than 3 megabases in HT29 colon carcinoma cells. | 1997 Aug | 1 |
62 | 8620460 | Synergistic inhibitory effects of interferon-alpha and 5-fluorouracil in meningioma cells in vitro. | 1996 Feb 27 | 1 |
63 | 8646722 | Phase II clinical trial with 5-fluorouracil, recombinant interferon-alpha-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus. | 1996 Jul 1 | 2 |
64 | 8758262 | Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-alpha-2b in patients with advanced gastric carcinoma. | 1996 Jun | 1 |
65 | 8823494 | Effect of interferon on 5-fluorouracil-induced perturbations in pools of deoxynucleotide triphosphates and DNA strand breaks. | 1996 | 6 |
66 | 8824349 | Phase I trial of high-dose infusional hydroxyurea, high-dose infusional 5-fluorouracil and recombinant interferon-alpha-2a in patients with advanced malignancies. | 1996 | 2 |
67 | 8826868 | A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer. | 1996 Sep | 2 |
68 | 8862717 | A phase I trial of 5-fluorouracil, leucovorin and interferon-alpha 2b administered by 24 h infusion in metastatic colorectal carcinoma. | 1996 Jul | 1 |
69 | 8874326 | Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer. | 1996 Oct | 1 |
70 | 8879370 | 5-Fluorouracil versus 5-fluorouracil plus alpha-interferon as treatment of metastatic colorectal carcinoma. A randomized study. | 1996 Aug | 1 |
71 | 8931668 | Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292. | 1996 Dec | 3 |
72 | 9229325 | High-dose infusional 5-fluorouracil combination therapy of metastatic gastric and colorectal cancer. | 1996 Summer | 1 |
73 | 7577043 | The role of interferon-alpha as a modulator of fluorouracil and leucovorin. | 1995 Jul-Aug | 2 |
74 | 7597304 | Biochemical modulation of cytotoxic drugs by cytokines: molecular mechanisms in experimental oncology. | 1995 | 7 |
75 | 7611752 | [Biomodulation of 5-fluorouracil by interferon]. | 1995 Jul | 6 |
76 | 7627962 | 5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression. | 1995 Aug 15 | 1 |
77 | 7634247 | Interferon-alpha-induced protection of renal cell cancer cell line from lysis by natural killer cells and increase of susceptibility by treatment with 5-fluorouracil. | 1995 Aug 1 | 2 |
78 | 7642571 | Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil. | 1995 Aug 11 | 5 |
79 | 7646900 | Treatment of advanced colorectal cancer with 5-fluorouracil and interferon-alpha: an overview of clinical trials. | 1995 Jun | 1 |
80 | 7666089 | Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancer. | 1995 Sep | 1 |
81 | 7669711 | Interferon-alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer. First results of a randomized multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO). | 1995 May | 1 |
82 | 7850703 | 5-Fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer. Effects of maintenance therapy on remission duration. | 1995 Mar 1 | 1 |
83 | 7882458 | A phase I study of recombinant human interferon alpha-2b combined with 5-fluorouracil and cisplatin in patients with advanced cancer. | 1995 | 3 |
84 | 8542247 | Pharmacokinetic interaction of 5-fluorouracil and interferon alpha-2b with or without folinic acid. | 1995 Mar | 2 |
85 | 21556603 | Long-term microcalorimetric findings in renal-cell carcinoma exposed to interferon-alpha-2a, interleukin-2 and 5-Fluorouracil. | 1995 Apr | 1 |
86 | 7516637 | Cisplatin, 5-fluorouracil and alpha interferon in non small cell lung carcinoma: a toxicity study. | 1994 Mar-Apr | 1 |
87 | 7812360 | Phase I study of interleukin-2 combined with interferon-alpha and 5-fluorouracil in patients with metastatic renal cell cancer. | 1994 Summer | 2 |
88 | 7847809 | Differential effects of recombinant interferon-alpha and 5-fluorouracil against colon cancer cells or against peripheral blood mononuclear cells. | 1994 Sep-Oct | 4 |
89 | 7923102 | Anti-proliferative activity of interferon-alpha on human squamous carcinoma of tongue cell lines. | 1994 Sep 30 | 1 |
90 | 7947102 | The effect of 5-fluorouracil and alpha interferon and 5-fluorouracil and leucovorin on cellular anti-tumour immune responses in patients with advanced colorectal cancer. | 1994 Nov | 4 |
91 | 8026229 | 5-Fluorouracil-interferon-alpha 2b adjuvant treatment of Dukes C colorectal cancer. | 1994 Jul | 3 |
92 | 8074466 | Recombinant human interferon alpha-2a increases 5-fluorouracil efficacy by elevating fluorouridine concentration in tumor tissue. | 1994 May-Jun | 2 |
93 | 8137250 | Potentiation of the antitumor activity of 5-fluorouracil in colon carcinoma cells by the combination of interferon and deoxyribonucleosides results from complementary effects on thymidine phosphorylase. | 1994 Mar 15 | 7 |
94 | 8186172 | Interferon-alpha, 5-FU and prednisone in metastatic renal cell carcinoma: a phase II study. | 1994 Mar | 3 |
95 | 8192103 | Double 5-fluorouracil modulation with folinic acid and recombinant alpha-2B-interferon. A phase I-II study in metastatic colorectal cancer patients. | 1994 Jun | 2 |
96 | 8221681 | Cytokinetic effects of interferon in colorectal cancer tumors: implications in the design of the interferon/5-fluorouracil combinations. | 1993 Nov 15 | 3 |
97 | 8239524 | Hematotoxicity of 5-fluorouracil and alpha-interferon on the human normal hemopoietic progenitors. | 1993 Sep-Oct | 1 |
98 | 8246910 | N-(phosphonacetyl)-L-aspartate synergistically enhances the cytotoxicity of 5-fluorouracil/interferon-alpha-2a against human colon cancer cell lines. | 1993 Nov | 2 |
99 | 8292812 | A phase II study of 5-fluorouracil, leucovorin and interferon-alpha in advanced pancreatic cancer. | 1993 Oct | 2 |
100 | 8336197 | Phase I trial of low-dose, prolonged continuous infusion fluorouracil plus interferon-alfa: evidence for enhanced fluorouracil toxicity without pharmacokinetic perturbation. | 1993 Aug | 3 |